Literature DB >> 23480964

Carcinoid tumors of the small-bowel: evaluation with 64-section CT-enteroclysis.

Philippe Soyer1, Anthony Dohan, Clarisse Eveno, Xavier Dray, Lounis Hamzi, Christine Hoeffel, Rachid Kaci, Mourad Boudiaf.   

Abstract

PURPOSE: To describe the imaging presentation of carcinoid tumors of the small-bowel at 64-section CT-enteroclysis and determine the sensitivity of this technique for tumor detection. PATIENTS AND METHODS: The 64-section CT-enteroclysis examinations of 22 patients with histopathologically proven small-bowel carcinoid tumors and those of 6 patients with suspected recurrence after small-bowel resection for carcinoid tumor were reviewed. Images were analyzed with respect to imaging presentation. Sensitivity, specificity, and accuracy, of 64-section CT-enteroclysis for the diagnosis of carcinoid tumor of the small-bowel were estimated with 95% confidence intervals (CIs).
RESULTS: Twenty-five carcinoid tumors were confirmed in 22 patients (prevalence, 22/28; 79%). Overall sensitivity for carcinoid tumor detection was 76% (19/25; 95%CI: 55-91%) on a per-lesion basis. On a per-patient basis, 64-section CT-enteroclysis had a sensitivity of 86% (19/22; 95%CI: 65-97%), a specificity of 100% (6/6; 95%CI: 54-100%) and an accuracy of 89% (25/28; 95%CI: 72-98%) for the diagnosis of carcinoid tumor. Focal small-bowel wall thickening, mesenteric stranding, and mesenteric mass were found in 20/22 (91%), 18/22 (82%) and 15/22 (68%) patients with pathologically confirmed tumors.
CONCLUSION: 64-Section CT-enteroclysis shows highly suggestive features for the diagnosis of carcinoid tumor of the small-bowel and achieves high degrees of sensitivity for tumor detection.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23480964     DOI: 10.1016/j.ejrad.2013.02.013

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  7 in total

Review 1.  Update on imaging of Peutz-Jeghers syndrome.

Authors:  Catherine Tomas; Philippe Soyer; Anthony Dohan; Xavier Dray; Mourad Boudiaf; Christine Hoeffel
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

2.  Detection of small-bowel tumours with CT enteroclysis using carbon dioxide and virtual enteroscopy: A preliminary study.

Authors:  Anthony Dohan; Mourad Boudiaf; Xavier Dray; Elia Samaha; Christophe Cellier; Marine Camus; Clarisse Eveno; Raphael Dautry; Philippe Soyer
Journal:  Eur Radiol       Date:  2017-07-14       Impact factor: 5.315

Review 3.  Role of computed tomography angiography in detection and staging of small bowel carcinoid tumors.

Authors:  David Bonekamp; Siva P Raman; Karen M Horton; Elliot K Fishman
Journal:  World J Radiol       Date:  2015-09-28

Review 4.  The Surgical Management of Small Bowel Neuroendocrine Tumors: Consensus Guidelines of the North American Neuroendocrine Tumor Society.

Authors:  James R Howe; Kenneth Cardona; Douglas L Fraker; Electron Kebebew; Brian R Untch; Yi-Zarn Wang; Calvin H Law; Eric H Liu; Michelle K Kim; Yusuf Menda; Brian G Morse; Emily K Bergsland; Jonathan R Strosberg; Eric K Nakakura; Rodney F Pommier
Journal:  Pancreas       Date:  2017-07       Impact factor: 3.327

5.  Performance of Multidetector Computed Tomography and Negative Versus Positive Enteric Contrast for Evaluation of Gastrointestinal Neuroendocrine Neoplasms.

Authors:  Ajaykumar C Morani; Shiva Gupta; Khaled M Elsayes; Ahmad I Mubarak; Ahmed M Khalaf; Priya R Bhosale; Jia Sun; Corey T Jensen; Vikas Kundra
Journal:  J Comput Assist Tomogr       Date:  2022-03-04       Impact factor: 2.081

Review 6.  [Neuroendocrine tumors of the abdomen].

Authors:  M Juchems
Journal:  Radiologe       Date:  2018-01       Impact factor: 0.635

Review 7.  Gastrointestinal neuroendocrine neoplasms (GI-NENs): hot topics in morphological, functional, and prognostic imaging.

Authors:  Ginevra Danti; Federica Flammia; Benedetta Matteuzzi; Diletta Cozzi; Valentina Berti; Giulia Grazzini; Silvia Pradella; Laura Recchia; Luca Brunese; Vittorio Miele
Journal:  Radiol Med       Date:  2021-08-24       Impact factor: 3.469

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.